Yahoo Web Search

Search results

1. www.nature.com › articles › d42473/020/00499-wLeading clinical trials for cancer - Nature

   www.nature.com › articles › d42473/020/00499-w

   • Cached

   Here, the president of CHCAMS, and NCC director, Jie He, discusses CHCAMS’s role in standardizing China’s cancer clinical trials. Credit: Cancer Hospital, Chinese Academy of Medical...

2. Images

   • 
   • 
   • 
   • 
   • 

   View all

3. www.sciencedirect.com › author › 57209705058Jie He | ScienceDirect

   www.sciencedirect.com › author › 57209705058

   Jie He. Author information. Current affiliation: Cancer Institute & Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Scopus ID: 57209705058. 33,364. Citations from 30,265 documents. 436. Documents. 63. h -index. 3. Preprints. 1,797. Co-authors. View full profile in Scopus. Request profile edit.

4. www.researchgate.net › Jie-He-2163448498Jie He's research works | Renmin University of China, Beijing ...

   www.researchgate.net › Jie-He-2163448498

   Jie He's 130 research works with 21,226 citations and 19,796 reads, including: Prediction of Tumor Microenvironment Characteristics and Treatment Response in Lung Squamous Cell Carcinoma by...

5. www.nature.com › articles › ngGenetic landscape of esophageal squamous cell carcinoma - Nature

   www.nature.com › articles › ng

   Aug 24, 2014 · Nature Genetics - Jie He and colleagues report exome sequencing of 113 tumor-normal pairs of esophageal squamous cell carcinoma. They highlight mutations in genes involved in cell cycle and ...

   • Author: Yi Bo Gao, Zhao Li Chen, Jia Gen Li, Xue Da Hu, Xue Jiao Shi, Zeng Miao Sun, Fan Zhang, Zi Ran Zhao,...

   • Publish Year: 2014

6. www.iarc.who.int › news-events › iarc-and-theIARC and the National Cancer Center of China launch a ...

   www.iarc.who.int › news-events › iarc-and-the

   • Cached

   May 10, 2023 · The International Agency for Research on Cancer (IARC) and the National Cancer Center of China (NCC China) are setting up an IARC-NCC China Learning Centre to train researchers and practitioners and to foster collaborative cancer prevention research and activities across China and the region.

7. orcid.org › 0000/0003/4432-8318Jie He (0000-0003-4432-8318) - ORCID

   orcid.org › 0000/0003/4432-8318

   Chinese Academy of Medical Sciences Cancer Institute and Hospital: Chaoyang District, Beijing, CN. (Thoracic Surgery) Employment. Show more detail. Source : Jie He.

8. People also ask

   Where are cancer clinical trials conducted in China?

   • Cancer is the focus of countless researchers and drug developers. In China, a leader in cancer clinical trials is the Cancer Hospital, Chinese Academy of Medical Sciences (CHCAMS). Housing the National Cancer Center (NCC), its Clinical Trials Center is one of China’s first for anti-cancer drugs.

   Leading clinical trials for cancer - Nature

   www.nature.com/articles/d42473-020-00499-w

   See all results for this question

   What did China do for Cancer Research?

   • We established China’s first ethics committee for cancer clinical trials, led China’s first international multicentre trial of anti-cancer drugs, set technical standards for clinical studies, and cultivated many professionals for cancer trials.

   Leading clinical trials for cancer - Nature

   www.nature.com/articles/d42473-020-00499-w

   See all results for this question

   Who is China's first hospital to conduct international multicentre trials?

   • As China’s first hospital to conduct international multicentre trials, we have led clinical trials for Bristol-Myers Squibb, Sanofi, Pfizer, Roche, and AstraZeneca on their products, which have provided high-quality treatment options for Chinese cancer patients.

   Leading clinical trials for cancer - Nature

   www.nature.com/articles/d42473-020-00499-w

   See all results for this question

   Is a holistic approach to cancer prevention suitable for the Chinese population?

   • From epidemiological studies and investigations on the biological mechanisms of cancer etiology and progression, to clinical studies on the effects of new drugs or intervention technologies, we are exploring a holistic approach to cancer prediction, prevention and treatment, which is specifically suitable for the Chinese population.

   Leading clinical trials for cancer - Nature

   www.nature.com/articles/d42473-020-00499-w

   See all results for this question

9. www.emedevents.com › speaker-profile › jie-heJie He, Chairman, Professor - eMedEvents

   www.emedevents.com › speaker-profile › jie-he

   • Cached

   Aug 24, 2019 · He serves as Chairman-elect of Chinese Society for Thoracic and Cardiovascular Surgery, Honorary Chairman of Esophagus Cancer Professional Board of Chinese Anti-cancer Association, Chairman-elect of CMDA Thoracic Surgeon Branch, and Editor-in-chief of journals like Chinese Journal of Oncology and China Cancer.